95 related articles for article (PubMed ID: 3568864)
1. [Nephrotic syndrome and hypercoagulable state].
Zhou XJ; Zhuo HY; Liu YQ
Zhonghua Nei Ke Za Zhi; 1986 Dec; 25(12):729-31, 776. PubMed ID: 3568864
[No Abstract] [Full Text] [Related]
2. [Primary nephrotic syndrome treated with urokinase--a report of 20 cases].
Wang LS; Chen EH; Zhou XJ
Zhonghua Nei Ke Za Zhi; 1989 Jun; 28(6):356-9, 382. PubMed ID: 2582915
[TBL] [Abstract][Full Text] [Related]
3. [A study on the urokinase treatment in patients with glomerulonephritis and nephrotic syndrome].
Konishi K; Kato E; Iyori S; Higashi F
Nihon Jinzo Gakkai Shi; 1982 Apr; 24(4):429-44. PubMed ID: 6750187
[No Abstract] [Full Text] [Related]
4. [Fibrinolytic system in patients with nephrotic syndrome].
Andreenko GV; Poliantseva LR; Smirnova TA; Podorol'skaia LV
Ter Arkh; 1976; 40(2):89-99. PubMed ID: 135367
[No Abstract] [Full Text] [Related]
5. [Studies on the fibrinolytic therapy in patients with various renal diseases. Clinical effects of urokinase (author's transl)].
Takasaki H; Shibata M
Nihon Jinzo Gakkai Shi; 1981 Sep; 23(9):1271-80. PubMed ID: 7035725
[No Abstract] [Full Text] [Related]
6. [Effect of urokinase therapy in patients with glomerulonephritis and nephrotic syndrome. Trial at multiple institutes in Japan].
Tomura S; Takeuchi J; Tanaka K
Nihon Jinzo Gakkai Shi; 1984 Jan; 26(1):97-121. PubMed ID: 6376892
[No Abstract] [Full Text] [Related]
7. [Studies on the fibrinolytic therapy in the patients with nephrotic syndrome (author's transl)].
Shibata M; Shimizu K; Kishi T; Kobayashi K; Sakai H; Sugiyama H; Oguri M
Nihon Jinzo Gakkai Shi; 1980 Sep; 22(9):1197-207. PubMed ID: 6450847
[No Abstract] [Full Text] [Related]
8. Plasminogen activator in nephrotic syndrome.
Andreenko GV; Podoroldskaya LV; Polyantseva LP
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):351-5. PubMed ID: 2465229
[TBL] [Abstract][Full Text] [Related]
9. [Adrenal cortex function in nephrotic syndrome].
Kinoshita Y; Hoshino T
Saishin Igaku; 1967 Feb; 22(2):315-26. PubMed ID: 4294296
[No Abstract] [Full Text] [Related]
10. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.
Vaziri ND; Gonzales EC; Shayestehfar B; Barton CH
J Lab Clin Med; 1994 Jul; 124(1):118-24. PubMed ID: 7518491
[TBL] [Abstract][Full Text] [Related]
11. [A study of urokinase lysis time in patients with various renal diseases].
Shimizu K; Kishi T; Ootaka M; Yamamoto J; Shibata M; Ban I; Sakai H; Kobayashi K
Nihon Jinzo Gakkai Shi; 1982 Nov; 24(11):1233-41. PubMed ID: 6762457
[No Abstract] [Full Text] [Related]
12. Relationship between histologic findings and effects of glucocorticoid therapy on the nephrotic syndrome.
Kinoshita Y; Kosokabe K; Yokoyama Y; Morita T
Acta Med Biol (Niigata); 1965 Jun; 13(1):79-94. PubMed ID: 5852290
[No Abstract] [Full Text] [Related]
13. High dose urokinase against massive pulmonary embolism in nephrotic syndrome.
Chen G; Liu Y; Xie Y; Li J; Liu H; Sun L; Peng Y; Liu F
Blood Coagul Fibrinolysis; 2013 Jun; 24(4):439-43. PubMed ID: 23386277
[TBL] [Abstract][Full Text] [Related]
14. [Fatty acid analysis by gas-liquid chromatography in the field of pediatrics. 2. Fatty acid composition in kidney diseases in children with special reference to nephrotic syndrome and its variation due to adrenocortical hormone therapy].
Sekiya S
Nihon Shonika Gakkai Zasshi; 1969 Nov; 73(11):1783-8. PubMed ID: 5393372
[No Abstract] [Full Text] [Related]
15. Treatment of the nephrotic syndrome in out-patients.
Pochanugool C; Suvanpha R; Sitprija V
J Med Assoc Thai; 1979 Jul; 62(7):345-9. PubMed ID: 479719
[No Abstract] [Full Text] [Related]
16. [Cholesterol level and content of calcium and magnesium in plasma in nephrotic syndrome in children].
Halikowski B; Kucharska K; Sancewicz-Pach K
Pediatr Pol; 1969 May; 44(5):561-6. PubMed ID: 5791320
[No Abstract] [Full Text] [Related]
17. [C D-S mixture (Chinese herbal drugs) in the treatment of hyper-hemoviscosity state in nephrotic syndrome and analysis of its therapeutic effects].
Zhu PJ
Zhong Xi Yi Jie He Za Zhi; 1988 Apr; 8(4):207-9, 195. PubMed ID: 3191541
[No Abstract] [Full Text] [Related]
18. [Results of corticotherapy in the primary nephrotic syndromes in adults].
Fries D; Brunat N; François B; Traeger J
J Urol Nephrol (Paris); 1965 Sep; 71(9):714-27. PubMed ID: 5859056
[No Abstract] [Full Text] [Related]
19. [A study of fibrinolytic therapy in glomerulonephritis and nephrotic syndrome. III. Indication, time to start therapy and criteria of effect (author's transl)].
Sato M; Nakazora H; Ohfuji T
Nihon Jinzo Gakkai Shi; 1977 Sep; 19(9):717-31. PubMed ID: 599731
[No Abstract] [Full Text] [Related]
20. [Antimitotic drugs in the treatment of the nephrotic syndrome].
Perlińska-Schnejder L; Gutka A
Pol Tyg Lek; 1968 Sep; 23(34):1276-7. PubMed ID: 5722526
[No Abstract] [Full Text] [Related]
[Next] [New Search]
